Search details
1.
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.
Proc Natl Acad Sci U S A
; 111(3): 1114-9, 2014 Jan 21.
Article
in English
| MEDLINE | ID: mdl-24395800
2.
MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.
Oncotarget
; 7(17): 23300-11, 2016 Apr 26.
Article
in English
| MEDLINE | ID: mdl-27004400
3.
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
JAMA Oncol
; 1(2): 238-44, 2015 May.
Article
in English
| MEDLINE | ID: mdl-26181029
4.
Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck.
Clin Med Insights Ther
; 2013(5)2013.
Article
in English
| MEDLINE | ID: mdl-24273416
5.
eIF2α kinases regulate development through the BzpR transcription factor in Dictyostelium discoideum.
PLoS One
; 7(3): e32500, 2012.
Article
in English
| MEDLINE | ID: mdl-22403666
Results
1 -
5
de 5
1
Next >
>>